Expression status of stemness-related genes in nonalcoholic steatohepatitis and clarification of the carcinogenesis mechanism
Project/Area Number |
26461024
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Tokyo Women's Medical University |
Principal Investigator |
Kogiso Tomomi 東京女子医科大学, 医学部, 准講師 (10318082)
|
Co-Investigator(Kenkyū-buntansha) |
橋本 悦子 東京女子医科大学, 医学部, 教授 (40130273)
山本 雅一 東京女子医科大学, 医学部, 教授 (60220498)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | steatohepatitis / stemness marker / hepatocellular carcinoma / 非アルコール性脂肪肝炎 / stemness遺伝子 / Nanog / EpCAM / 非アルコール性脂肪肝炎 (NASH) / 肝癌(HCC) / 非アルコール性脂肪肝炎(NASH) |
Outline of Final Research Achievements |
1)Nanog was expressed in 85% of liver tissue from patients with nonalcoholic steatohepatitis (NASH), and EpCAM was expressed in 45%. 2) A comparison of clinical parameters between patients with strongly positive/weakly positive Nanog expression revealed total-bilirubin of 0.9/0.4 mg/dL, alanine transaminase of 47/22 U/L, prothrombin time (PT) of 84/100%, and fasting blood sugar of 104/227 mg/dL with significant differences (p < 0.05). PT% was higher in the weakly positive EpCAM group (81/ 98%) than that in the strongly positive EpCAM group. 3) EpCAM expression was higher in advanced fibrosis cases. Nanog expression was higher in cases of NASH-hepatocellular carcinoma (HCC); therefore, it may be important in the initiation of HCC. 4) The iTRAQ technique, which detects protein expression, led to the detection of 4,000 candidate proteins. Each protein was evaluated for its role in HCC initiation and progression.
|
Report
(4 results)
Research Products
(39 results)
-
-
-
[Journal Article] Successful Treatment of Ascites using a Denver<sup>®</sup> Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome2016
Author(s)
Kogiso T, Hashimoto E, Ito T, Hara T, Ikarashi Y, Kodama K, Taniai M, Torii N, Yoshinaga K, Morita S, Takahashi Y, Tanaka J, Sakai S, Yamamoto M, Tokushige K.
-
Journal Title
Internal Medicine
Volume: 55
Issue: 20
Pages: 2957-2963
DOI
NAID
ISSN
0918-2918, 1349-7235
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
[Journal Article] Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.2016
Author(s)
Tokushige K, Hyogo H, Nakajima T, Ono M, Kawaguchi T, Honda K, Eguchi Y, Nozaki Y, Kawanaka M, Tanaka S, Imajo K, Sumida Y, Kamada Y, Fujii H, Suzuki Y, Kogiso T, Karino Y, Munekage K, Kuromatsu R, Oeda S, Yanase M, Mori K, Ogawa Y, Seko Y, Takehara T, Itoh Y, Nakajima A, Kanemasa K, Saibara T
-
Journal Title
J Gastroenterol
Volume: 印刷中
Issue: 6
Pages: 586-96
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] A case report: primary hyperoxaluria complicated with liver cirrhosis.2015
Author(s)
1.Kogiso T, Tokushige K, Hashimoto E, Miyakata C, Taniai M, Torii N, Omori A, Kotera Y, Egawa H, Yamamoto M, Nagata M, Shiratori K.
-
Journal Title
Hepatol Res.
Volume: なし
Issue: 12
Pages: 1251-5
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.2015
Author(s)
Tokushige K, Hyogo H, Nakajima T, Ono M, Kawaguchi T, Honda K, Eguchi Y, Nozaki Y, Kawanaka M, Tanaka S, Imajo K, Sumida Y, Kamada Y, Fujii H, Suzuki Y, Kogiso T, et al.
-
Journal Title
J Gastroenterol.
Volume: なし
Related Report
Peer Reviewed
-
[Journal Article] Daclatasvir/Asunaprevir Therapy Provides High Tolerability and Effectiveness for HCV-Positive Kidney Transplant Recipients.2015
Author(s)
Kogiso T, Hashimoto E, Yamamoto K, Ikarashi Y, Kodama K, Taniai M, Torii N, Tanabe K, Ishida H, Fuchinoue S, Tokushige K.
-
Journal Title
J Liver: Dis Transplant
Volume: 4
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
[Presentation] Risk factors for hepatocellular carcinoma recurrence in patients with nonalcoholic and alcoholic fatty liver diseases: A Japanese multicenter survey2015
Author(s)
Kogiso T, Hashimoto E, Hyogo H, Nakajima T, Ono M, Kawaguchi T, Honda K, Eguchi Y, Nozaki Y, Kawanaka M, Imajo K, Sumida Y, Kamada Y, Fujii H, Suzuki Y, and Tokushige K
Organizer
The 66th annual meeting of the American Association for the Study of Liver Diseases (AASLD),
Place of Presentation
San Francisco, U.S.A., Moscone West Convention Center
Year and Date
2015-11-13
Related Report
Int'l Joint Research
-
-
-
-
-
[Presentation] 移植後のC型肝炎ウイルス再感染の経過2015
Author(s)
小木曽智美, 徳重克年, 橋本悦子, 五十嵐悠一, 児玉和久, 谷合麻紀子, 鳥居信之, 白鳥敬子, 江川裕人, 山本雅一
Organizer
第101回日本消化器病学会総会
Place of Presentation
仙台 仙台国際センター
Year and Date
2015-04-23
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-